Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

Envoy Medical (COCH) Shares Issued (2023 - 2026)

Envoy Medical's Shares Issued history spans 4 years, with the latest figure at $30.0 million for Q1 2026.

On a quarterly basis, Shares Issued changed N/A to $30.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $29.4 million, a N/A change, with the full-year FY2025 number at $414000.0, down 77.19% from a year prior.
Shares Issued hit $30.0 million in Q1 2026 for Envoy Medical, up from -$2.1 million in the prior quarter.
Over the last five years, Shares Issued for COCH hit a ceiling of $30.0 million in Q1 2026 and a floor of -$2.1 million in Q4 2025.
Historically, Shares Issued has averaged $5.9 million across 4 years, with a median of $1.4 million in 2024.
The widest YoY moves for Shares Issued: up 63.59% in 2025, down 251.05% in 2025.
Tracing COCH's Shares Issued over 4 years: stood at $9.9 million in 2023, then crashed by 86.05% to $1.4 million in 2024, then tumbled by 251.05% to -$2.1 million in 2025, then soared by 1538.02% to $30.0 million in 2026.
Business Quant data shows Shares Issued for COCH at $30.0 million in Q1 2026, -$2.1 million in Q4 2025, and $158000.0 in Q3 2025.